Clinical Trials Browser

Phase 3 × Papillomavirus Infections × 1 year × Clear all

NCT05119855 2026-02-05

Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)

Phase 3 Completed

165 enrolled 13 charts

COVID-19, Papillomavirus Infections

NCT04255849 2026-01-23

Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV

Phase 3 Active not recruiting

Papillomavirus Infections

NCT06632912 2026-01-23

Phase IIIb Clinical Trial of Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) for Age/Immunization Schedule Bridging

Phase 3 Active not recruiting

Infections, Papillomavirus Infections

NCT05262010 2026-01-16

A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years

Phase 3 Recruiting

13,500 enrolled

Papillomavirus Infections

NCT01302834 2026-01-12

Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer

Phase 3 Completed

987 enrolled 59 charts

Head & NeckOther neoplasm

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Precancerous Conditions, Papillomavirus Infections

NCT04772534 2025-05-30

V503-066

Phase 3 Completed

314 enrolled 12 charts

Papillomavirus Infections

NCT04708041 2025-04-20

V503-069

Phase 3 Active not recruiting

Papillomavirus Infections

NCT04199689 2025-03-25

V503-049

Phase 3 Active not recruiting

Papillomavirus Infections

NCT03903562 2025-03-24

V503-024

Phase 3 Completed

Papillomavirus Infections